-

AdvanSix Announces Third Quarter 2025 Financial Results

3Q25 Sales of $374 million, down 6% versus prior year

3Q25 Earnings Per Share of ($0.10); Adjusted Earnings Per Share of $0.08

3Q25 Cash Flow from Operations of $27 million

PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix (NYSE: ASIX), a diversified chemistry company, today announced its financial results for the third quarter ending September 30, 2025. Overall, the Company continued to navigate challenging industry dynamics with a focus on optimizing operational and commercial performance.

Third Quarter 2025 Summary

"In the third quarter, our team executed with agility and discipline as we seasonally entered a new fertilizer year in Plant Nutrients with a strong fall fill program, amid higher raw material input costs, while continuing to realize the ongoing benefits from our SUSTAIN growth program,” said Erin Kane, president and CEO of AdvanSix. “In the face of continued weak market conditions in Nylon Solutions and lower net pricing in Chemical Intermediates year over year as anticipated, we are making the strategic choice to moderate production rates to manage inventory levels with a keen focus on free cash flow. We have a demonstrated track record of navigating through cycles and complex dynamics, and our durable competitive advantage will serve us well through this time."

Summary third quarter 2025 financial results for the Company are included below:

($ in Thousands, Except Earnings Per Share)

3Q 2025

 

3Q 2024

 

Variance

Sales

$374,473

 

$398,187

 

($23,714)

Net Income (Loss)

(2,638)

 

22,266

 

(24,904)

Diluted Earnings Per Share

(0.10)

 

0.82

 

(0.92)

Adjusted Diluted Earnings Per Share (1)

0.08

 

0.88

 

(0.80)

Adjusted EBITDA (1)

24,734

 

53,161

 

(28,427)

Adjusted EBITDA Margin % (1)

6.6%

 

13.4%

 

(680) bps

Cash Flow from Operations

26,588

 

57,250

 

(30,662)

Capital Expenditures

26,522

 

30,490

 

(3,968)

Free Cash Flow (1)(2)

66

 

26,760

 

(26,694)

(1) 

See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations

(2)

Net cash provided by operating activities less capital expenditures

Sales of $374 million in the quarter decreased approximately 6% versus the prior year. Sales volume decreased approximately 3% primarily driven by softer demand in chemical intermediates and nylon end markets. Raw material pass-through pricing was down approximately 5% following a net cost decrease in benzene and propylene (inputs to cumene which is a key feedstock to our products). Market-based pricing was favorable by approximately 2% driven by continued strength in Plant Nutrients reflecting favorable North American ammonium sulfate supply and demand conditions.

Sales by product line and approximate percentage of total sales are included below:

($ in Thousands)

3Q 2025

 

3Q 2024 (1)

 

Sales

 

% of Total

 

Sales

 

% of Total

Nylon

$

79,029

 

21

%

 

$

93,693

 

24

%

Caprolactam

 

73,137

 

20

%

 

 

76,338

 

19

%

Plant Nutrients

 

138,661

 

37

%

 

 

113,552

 

29

%

Chemical Intermediates

 

83,646

 

22

%

 

 

114,604

 

28

%

Total

$

374,473

 

100

%

 

$

398,187

 

100

%

(1) The Company transferred certain products between its Chemical Intermediates product line and its Plant Nutrients product line to align more closely with its current sales structure. Historical information has been reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements. Total revenue amounts were not impacted for either period.

Adjusted EBITDA of $24.7 million in the quarter decreased $28.4 million versus the prior year primarily driven by a decline in Chemical Intermediates pricing, net of raw material costs, and the impact of lower Nylon and Chemical Intermediates sales and production volume.

Adjusted earnings per share of $0.08 decreased $0.80 versus the prior year driven primarily by the factors discussed above.

Cash flow from operations of $26.6 million in the quarter decreased $30.7 million versus the prior year primarily due to lower net income. Capital expenditures of $26.5 million in the quarter decreased $4.0 million versus the prior year.

Outlook

  • Anticipate continued strength in Plant Nutrients amid higher raw material input costs supported by planned progression of SUSTAIN growth program
  • Acetone spread over refinery grade propylene costs are below 2024 multi-year highs, but expected to hold near cycle averages
  • Navigating an extended downturn in the nylon cycle - focused on controllable levers to optimize performance
  • Expect Capital Expenditures to now be approximately $120 to $125 million in 2025, reflecting $30 million of full year cash conservation through refined prioritization and focus on strong cash flow generation
  • Completed 4Q25 planned plant turnaround as expected (approximately $14 million pre-tax income impact)
  • Expect cash flow tailwind in 2026 from 45Q carbon capture tax credits and 100% bonus depreciation

"We are well-positioned as an American manufacturer of essential chemistries serving a diverse set of end market applications with alignment to domestic agriculture, manufacturing supply chains and energy markets. The current market backdrop has been mixed. We've seen continued strength in Plant Nutrients and acetone margins remain near cycle averages, while nylon has been more challenging. In times of uncertainty, we're focused on delivering on controllable levers. This includes continued optimization of production output and sales volume mix while driving productivity to support through-cycle profitability. Taking a disciplined approach to cash management is critical reflected in our prioritization of base capital investments and we anticipate tailwinds in 2026 from 45Q carbon capture tax credits. We are committed to delivering long-term value to our shareholders,” concluded Kane.

Dividend

The Company's Board of Directors declared a quarterly cash dividend of $0.16 per share on the Company's common stock. The dividend is payable on December 2, 2025 to stockholders of record as of the close of business on November 18, 2025.

Conference Call Information

AdvanSix will discuss its results during its investor conference call today starting at 9:30 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start, and tell the operator that you are dialing in for AdvanSix’s third quarter 2025 earnings call. The live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on Nov 7 until 12 noon ET on Nov 14 by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international). The access code is 9358968.

About AdvanSix

AdvanSix is a diversified chemistry company that produces essential materials for our customers in a wide variety of end markets and applications that touch people’s lives. Our integrated value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients, and chemical intermediates. More information on AdvanSix can be found at http://www.advansix.com.

Forward Looking Statements

This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally; the potential effects of inflationary pressures, tariffs or the imposition of new tariffs, trade wars, barriers or restrictions, or threats of such actions, changes in interest rates, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of new or proposed legislation or regulatory, trade or other policies in or impacting the U.S., the conflict between Russia and Ukraine, the conflicts in Israel, Gaza and Iran, and related uncertainty in the surrounding region, and the possible expansion of such conflicts; the effect of any of the foregoing on our customers’ demand for our products and our suppliers’ ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers’ offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks, data privacy incidents and disruptions to our technology infrastructure; risks associated with operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics, geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ materially from those contemplated by such forward-looking statements as a result of a number of risks, uncertainties and other factors including those noted above and those identified in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024, as updated in subsequent reports filed with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. We do not undertake to update or revise any of our forward-looking statements.

Non-GAAP Financial Measures

This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.

 
 

AdvanSix Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(Dollars in thousands, except share and per share amounts)

 

 

September 30, 2025

 

December 31, 2024

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

23,696

 

 

$

19,564

 

Accounts and other receivables – net

 

184,490

 

 

 

145,673

 

Inventories – net

 

209,120

 

 

 

212,386

 

Taxes receivable

 

23,758

 

 

 

503

 

Other current assets

 

13,931

 

 

 

8,990

 

Total current assets

 

454,995

 

 

 

387,116

 

Property, plant and equipment – net

 

943,332

 

 

 

917,858

 

Operating lease right-of-use assets

 

155,652

 

 

 

153,438

 

Goodwill

 

56,192

 

 

 

56,192

 

Intangible assets

 

40,857

 

 

 

43,144

 

Other assets

 

37,319

 

 

 

37,172

 

Total assets

$

1,688,347

 

 

$

1,594,920

 

 

 

 

 

LIABILITIES

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

236,053

 

 

$

228,761

 

Accrued liabilities

 

55,850

 

 

 

47,264

 

Income taxes payable

 

49

 

 

 

1,047

 

Operating lease liabilities – short-term

 

41,695

 

 

 

42,493

 

Deferred income and customer advances

 

681

 

 

 

37,538

 

Total current liabilities

 

334,328

 

 

 

357,103

 

Deferred income taxes

 

159,758

 

 

 

145,299

 

Operating lease liabilities – long-term

 

114,924

 

 

 

111,400

 

Line of credit – long-term

 

250,000

 

 

 

195,000

 

Postretirement benefit obligations

 

257

 

 

 

 

Other liabilities

 

10,848

 

 

 

11,468

 

Total liabilities

 

870,115

 

 

 

820,270

 

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

 

Common stock, par value $0.01; 200,000,000 shares authorized; 33,177,824 shares issued and 26,864,035 outstanding at September 30, 2025; 32,989,165 shares issued and 26,737,036 outstanding at December 31, 2024

 

332

 

 

 

330

 

Preferred stock, par value $0.01; 50,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2025 and December 31, 2024

 

 

 

 

 

Treasury stock at par (6,313,789 shares at September 30, 2025; 6,252,129 shares at December 31, 2024)

 

(63

)

 

 

(63

)

Additional paid-in capital

 

141,876

 

 

 

136,872

 

Retained earnings

 

670,264

 

 

 

631,541

 

Accumulated other comprehensive income

 

5,823

 

 

 

5,970

 

Total stockholders' equity

 

818,232

 

 

 

774,650

 

Total liabilities and stockholders' equity

$

1,688,347

 

 

$

1,594,920

 

AdvanSix Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(Dollars in thousands, except share and per share amounts)

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

2025

 

2024

 

2025

 

2024

Sales

$

374,473

 

 

$

398,187

 

$

1,162,286

 

 

$

1,188,495

 

 

 

 

 

 

 

 

Costs, expenses and other:

 

 

 

 

 

 

 

Costs of goods sold

 

349,088

 

 

 

340,885

 

 

1,024,716

 

 

 

1,046,860

Selling, general and administrative expenses

 

27,425

 

 

 

24,265

 

 

76,250

 

 

 

72,290

Interest expense, net

 

2,322

 

 

 

2,924

 

 

6,119

 

 

 

9,137

Other non-operating (income) expense, net

 

(815

)

 

 

368

 

 

(1,831

)

 

 

1,808

Total costs, expenses and other

 

378,020

 

 

 

368,442

 

 

1,105,254

 

 

 

1,130,095

 

 

 

 

 

 

 

 

Income (loss) before taxes

 

(3,547

)

 

 

29,745

 

 

57,032

 

 

 

58,400

Income tax expense (benefit)

 

(909

)

 

 

7,479

 

 

4,955

 

 

 

14,603

Net income (loss)

$

(2,638

)

 

$

22,266

 

$

52,077

 

 

$

43,797

 

 

 

 

 

 

 

 

Earnings per common share

 

 

 

 

 

 

 

Basic

$

(0.10

)

 

$

0.83

 

$

1.94

 

 

$

1.63

Diluted

$

(0.10

)

 

$

0.82

 

$

1.91

 

 

$

1.61

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

Basic

 

26,927,305

 

 

 

26,790,752

 

 

26,887,489

 

 

 

26,836,114

Diluted

 

26,927,305

 

 

 

27,204,714

 

 

27,248,759

 

 

 

27,209,680

AdvanSix Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(Dollars in thousands)

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

2025

 

2024

 

2025

 

2024

Cash flows from operating activities:

 

 

 

 

 

 

 

Net income (loss)

$

(2,638

)

 

$

22,266

 

 

$

52,077

 

 

$

43,797

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

20,327

 

 

 

18,933

 

 

 

58,966

 

 

 

57,197

 

(Gain) loss on disposal of assets

 

 

 

 

154

 

 

 

(177

)

 

 

415

 

Deferred income taxes

 

7,820

 

 

 

2,887

 

 

 

14,466

 

 

 

3,638

 

Stock-based compensation

 

1,632

 

 

 

1,559

 

 

 

5,919

 

 

 

5,963

 

Amortization of deferred financing fees

 

155

 

 

 

155

 

 

 

464

 

 

 

464

 

Operational asset adjustments

 

 

 

 

 

 

 

 

 

 

1,200

 

Changes in assets and liabilities, net of business acquisitions:

 

 

 

 

 

 

 

Accounts and other receivables

 

(24,977

)

 

 

21,073

 

 

 

(38,971

)

 

 

15,069

 

Inventories

 

12,644

 

 

 

(37,607

)

 

 

3,266

 

 

 

(1,603

)

Taxes receivable

 

(8,515

)

 

 

(196

)

 

 

(23,255

)

 

 

1,059

 

Accounts payable

 

4,123

 

 

 

17,994

 

 

 

16,546

 

 

 

(43,687

)

Income taxes payable

 

(335

)

 

 

(572

)

 

 

(998

)

 

 

(7,598

)

Accrued liabilities

 

8,352

 

 

 

4,839

 

 

 

8,913

 

 

 

10,988

 

Deferred income and customer advances

 

(1,177

)

 

 

369

 

 

 

(36,857

)

 

 

(14,161

)

Other assets and liabilities

 

9,177

 

 

 

5,396

 

 

 

(1,218

)

 

 

(1,493

)

Net cash provided by operating activities

 

26,588

 

 

 

57,250

 

 

 

59,141

 

 

 

71,248

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Expenditures for property, plant and equipment

 

(26,522

)

 

 

(30,490

)

 

 

(88,849

)

 

 

(99,373

)

Other investing activities

 

(262

)

 

 

(2,317

)

 

 

(6,153

)

 

 

(6,053

)

Net cash used for investing activities

 

(26,784

)

 

 

(32,807

)

 

 

(95,002

)

 

 

(105,426

)

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Borrowings from line of credit

 

85,000

 

 

 

54,000

 

 

 

316,500

 

 

 

311,500

 

Repayments of line of credit

 

(75,000

)

 

 

(69,000

)

 

 

(261,500

)

 

 

(266,500

)

Principal payments of finance leases

 

(249

)

 

 

(260

)

 

 

(740

)

 

 

(762

)

Dividend payments

 

(4,296

)

 

 

(4,276

)

 

 

(12,876

)

 

 

(12,858

)

Purchase of treasury stock

 

(121

)

 

 

(42

)

 

 

(1,658

)

 

 

(10,427

)

Issuance of common stock

 

112

 

 

 

328

 

 

 

267

 

 

 

755

 

Net cash provided by (used for) financing activities

 

5,446

 

 

 

(19,250

)

 

 

39,993

 

 

 

21,708

 

 

 

 

 

 

 

 

 

Net change in cash and cash equivalents

 

5,250

 

 

 

5,193

 

 

 

4,132

 

 

 

(12,470

)

Cash and cash equivalents at beginning of period

 

18,446

 

 

 

12,105

 

 

 

19,564

 

 

 

29,768

 

Cash and cash equivalents at the end of period

$

23,696

 

 

$

17,298

 

 

$

23,696

 

 

$

17,298

 

 

 

 

 

 

 

 

 

Supplemental non-cash investing activities:

 

 

 

 

 

 

 

Capital expenditures included in accounts payable

 

 

 

 

$

14,894

 

 

$

15,018

 

AdvanSix Inc.

Non-GAAP Measures

(Dollars in thousands, except share and per share amounts)

Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

2025

 

2024

 

2025

 

2024

Net cash provided by operating activities

$

26,588

 

 

$

57,250

 

 

$

59,141

 

 

$

71,248

 

Expenditures for property, plant and equipment

 

(26,522

)

 

 

(30,490

)

 

 

(88,849

)

 

 

(99,373

)

Free cash flow (1)

$

66

 

 

$

26,760

 

 

$

(29,708

)

 

$

(28,125

)

 

 

 

 

 

 

 

 

(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment.

The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.

Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

2025

 

2024

 

2025

 

2024

Net income (loss)

$

(2,638

)

 

$

22,266

 

 

$

52,077

 

 

$

43,797

 

Non-cash stock-based compensation

 

1,632

 

 

 

1,559

 

 

 

5,919

 

 

 

5,963

 

Non-recurring, unusual or extraordinary expense (2)

 

 

 

 

 

 

 

 

 

 

1,200

 

Non-cash amortization from acquisitions

 

532

 

 

 

531

 

 

 

1,595

 

 

 

1,595

 

Strategic advisory and professional fees (3)

 

4,000

 

 

 

 

 

 

4,000

 

 

 

 

Income tax benefit relating to reconciling items

 

(1,378

)

 

 

(367

)

 

 

(2,287

)

 

 

(1,594

)

Adjusted Net income (non-GAAP)

 

2,148

 

 

 

23,989

 

 

 

61,304

 

 

 

50,961

 

Interest expense, net

 

2,322

 

 

 

2,924

 

 

 

6,119

 

 

 

9,137

 

Income tax expense - Adjusted

 

469

 

 

 

7,846

 

 

 

7,242

 

 

 

16,197

 

Depreciation and amortization - Adjusted

 

19,795

 

 

 

18,402

 

 

 

57,371

 

 

 

55,602

 

Adjusted EBITDA (non-GAAP)

$

24,734

 

 

$

53,161

 

 

$

132,036

 

 

$

131,897

 

 

 

 

 

 

 

 

 

Sales

$

374,473

 

 

$

398,187

 

 

$

1,162,286

 

 

$

1,188,495

 

 

 

 

 

 

 

 

 

Adjusted EBITDA Margin (non-GAAP) (4)

 

6.6

%

 

 

13.4

%

 

 

11.4

%

 

 

11.1

%

 

 

 

 

 

 

 

 

(2) 2024 includes a pre-tax loss of approximately $1.2 million from the reduction of the Company's anticipated receivable related to the gain on the termination fee recorded upon the exit from the Oben Holding Group S.A. alliance during the third quarter of 2023

(3) Legal and professional fees associated with strategic regulatory matters and potential inorganic growth options

(4) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

2025

 

2024

 

 

2025

 

2024

Net income (loss)

$

(2,638

)

 

$

22,266

 

$

52,077

 

$

43,797

Adjusted Net income (non-GAAP)

 

2,148

 

 

 

23,989

 

 

61,304

 

 

50,961

 

 

 

 

 

 

 

 

Weighted-average number of common shares outstanding - basic

 

26,927,305

 

 

 

26,790,752

 

 

26,887,489

 

 

26,836,114

Dilutive effect of equity awards and other stock-based holdings

 

 

 

 

413,962

 

 

361,270

 

 

373,566

Weighted-average number of common shares outstanding - diluted

 

26,927,305

 

 

 

27,204,714

 

 

27,248,759

 

 

27,209,680

 

 

 

 

 

 

 

 

EPS - Basic

$

(0.10

)

 

$

0.83

 

$

1.94

 

$

1.63

EPS - Diluted

$

(0.10

)

 

$

0.82

 

$

1.91

 

$

1.61

Adjusted EPS - Basic (non-GAAP)

$

0.08

 

 

$

0.90

 

$

2.28

 

$

1.90

Adjusted EPS - Diluted (non-GAAP)

$

0.08

 

 

$

0.88

 

$

2.25

 

$

1.87

     

The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations.

AdvanSix Inc.

Appendix

(Pre-tax income impact, Dollars in millions)

Planned Plant Turnaround Schedule (4)

 

 

1Q

2Q

3Q

4Q

FY

Primary Unit Operation

2017

~$10

~$4

~$20

~$34

Sulfuric Acid

2018

~$2

~$10

~$30

~$42

Ammonia

2019

~$5

~$5

~$25

~$35

Sulfuric Acid

2020

~$2

~$7

~$20

~$2

~$31

Ammonia

2021

~$3

~$8

~$18

~$29

Sulfuric Acid

2022

~$1

~$5

~$44(5)

~$50

Ammonia

2023

~$2

~$1

~$27

~$30

Sulfuric Acid

2024

~$5

~$3

~$3

~$47(6)

~$58

Ammonia

2025E

~$5

~$6

~$14

~$25

Sulfuric Acid

(4) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.

(5) During the multi-site planned plant turnaround, additional required maintenance at our Frankford phenol plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates at our Hopewell and Chesterfield sites, resulting in an incremental $15 million unfavorable impact to pre-tax income, which is reflected in this amount and is inclusive of fixed cost absorption, higher maintenance expense and lost sales.

(6) During the multi-site planned plant turnaround, additional required maintenance at our Hopewell plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates, resulting in an incremental approximately $17 million unfavorable impact to pre-tax income, which is reflected in this amount and is inclusive of fixed cost absorption, higher maintenance expense, and lost sales.

 

Contacts

Media
Janeen Lawlor
(973) 526-1615
janeen.lawlor@advansix.com

Investors
Adam Kressel
(973) 526-1700
adam.kressel@advansix.com

AdvanSix

NYSE:ASIX

Release Summary
AdvanSix Announces Third Quarter 2025 Financial Results
Release Versions

Contacts

Media
Janeen Lawlor
(973) 526-1615
janeen.lawlor@advansix.com

Investors
Adam Kressel
(973) 526-1700
adam.kressel@advansix.com

Social Media Profiles
More News From AdvanSix

AdvanSix to Release Third Quarter Financial Results and Hold Investor Conference Call on November 7

PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix To Release Third Quarter Financial Results And Hold Investor Conference Call On November 7...

AdvanSix Appoints Dana O’Brien and Daryl Roberts to Board of Directors

PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix Appoints Dana O'Brien And Daryl Roberts To Board Of Directors...

AdvanSix Announces Second Quarter 2025 Financial Results

PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix Announces Second Quarter 2025 Financial Results...
Back to Newsroom